A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
for Sickle Cell Disease
35 locations incl. Mobile
Sponsor: Pfizer
Sex: All·Age: 12+
Code: NCT05431088·Phase 2, Phase 3·Recruiting·Listed Jun 2022
Saint Mary's Medical Center
Clinical research site in West Palm Beach, Florida · 901 45TH ST, WEST PALM BEACH, FL 33407-2413 · (561) 844-6300
As of September 2026, 20 paid clinical trials are recruiting at Saint Mary's Medical Center in West Palm Beach, Florida. Active studies at this site cover conditions such as B Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia and Ganglioneuroblastoma, Nodular. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at Saint Mary's Medical Center? We'll email you when one opens.
Recruiting clinical trials at Saint Mary's Medical Center (20)
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for Childhood Extracranial Germ Cell Tumor
382 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: All ages
Code: NCT03067181·Phase 3·Recruiting·Listed Mar 2017
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
for Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
381 locations incl. Birmingham
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 5 - 60
Code: NCT05675410·Phase 3·Recruiting·Listed Jan 2023
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for Hematopoietic and Lymphatic System Neoplasm
191 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: Female·Age: Up to 39
Code: NCT06513962·Phase 3·Recruiting·Listed Jul 2024
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for B Acute Lymphoblastic Leukemia
187 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: 365 Days - 25
Code: NCT03959085·Phase 3·Recruiting·Listed May 2019
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for Down Syndrome
152 locations incl. Birmingham
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 1 - 30
Code: NCT04546399·Phase 2·Recruiting·Listed Sep 2020
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for B Acute Lymphoblastic Leukemia
138 locations incl. Birmingham
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 366 Days - 46
Code: NCT06124157·Phase 2·Recruiting·Listed Nov 2023
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for Acute Myeloid Leukemia
169 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 21
Code: NCT04293562·Phase 3·Recruiting·Listed Mar 2020
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for Acute Leukemia of Ambiguous Lineage
111 locations incl. Birmingham
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: Up to 365 Days
Code: NCT06317662·Phase 2·Recruiting·Listed Mar 2024
Project: Every Child for Younger Patients With Cancer
for Adrenal Gland Pheochromocytoma
227 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 25
Code: NCT02402244·Recruiting·Listed Mar 2015
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for Stage I Mixed Cell Type Kidney Wilms Tumor
153 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 30
Code: NCT06401330·Phase 3·Recruiting·Listed May 2024
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
for Anaplastic Kidney Wilms Tumor
172 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 30
Code: NCT04322318·Phase 2·Recruiting·Listed Mar 2020
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for Ganglioneuroblastoma, Nodular
154 locations incl. Birmingham
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: Up to 30
Code: NCT06172296·Phase 3·Recruiting·Listed Dec 2023
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
for Acute Lymphoblastic Leukemia
156 locations incl. Birmingham
Sponsor: PedAL BCU, LLC
Sex: All·Age: Up to 22
Code: NCT04726241·Phase 1, Phase 2·Recruiting·Listed Jan 2021
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
for Ganglioneuroblastoma
143 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: 365 Days - 30
Code: NCT03126916·Phase 3·Recruiting·Listed Apr 2017
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for Embryonal Rhabdomyosarcoma
164 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 21
Code: NCT05304585·Phase 3·Recruiting·Listed Mar 2022
Hyperbaric Oxygen Brain Injury Treatment Trial
for Traumatic Brain Injury
8 locations incl. San Diego
Sponsor: Gaylan Rockswold
Sex: All·Age: 16 - 65
Code: NCT02407028·Phase 2·Recruiting·Listed Apr 2015
PUSH-IT Continuing Enteral Feeds for Tracheostomy
for Tracheostomy Complication
6 locations incl. Danbury
Sponsor: State University of New York at Buffalo
Sex: All·Age: 18+
Code: NCT05906472·Recruiting·Listed Jun 2023
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
for Acute Ischemic Stroke
51 locations incl. Mobile
Sponsor: Mercy Health Ohio
Sex: All·Age: 18 - 79
Code: NCT05611242·Phase 3·Recruiting·Listed Nov 2022
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for Rhabdomyosarcoma
85 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 50
Code: NCT07466316·Phase 3·Recruiting·Listed Mar 2026
Get new-trial alerts for Saint Mary's Medical Center
We'll email you whenever a new clinical trial starts recruiting at this research site in West Palm Beach, FL. Unsubscribe anytime.
More research sites in West Palm Beach
- Health Synergy Clinical Research (14 trials)
- Florida Cancer Specialists - East (10 trials)
- Metabolic Research Institute (6 trials)
- Florida Cancer Specialists East (5 trials)
- Palm Beach Research Center (5 trials)
- Florida Cancer Specialists (4 trials)
- St. Mary's Medical Center (4 trials)
- GSK Investigational Site (3 trials)
- Florida Cancer Specialists & Research Institute (3 trials)
- Florida Cancer Specialists - EAST - SCRI - PPDS (3 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in West Palm Beach, FL · Florida clinical trials